ProCE Banner Activity

The Patient Perspective on Navigating the Path of Rare Kidney Disease: Challenges, Impact, and Hope of New Therapies

Clinical Thought

Read a patient’s perspective on navigating life with primary hyperoxaluria, including how involvement with organizations such as the Oxalosis and Hyperoxaluria Foundation changed their perspective on their disease, as well as their experience participating in a clinical trial.

Released: March 14, 2024

Share

Faculty

John C. Lieske

John C. Lieske, MD

Professor of Medicine
Mayo Clinic
Division of Nephrology and Hypertension
Rochester, Minnesota

George Tidmore (Patient)

George Tidmore (Patient)

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Novo Nordisk.

Novo Nordisk

Disclosure

Primary Author

John C. Lieske, MD

Professor of Medicine
Mayo Clinic
Division of Nephrology and Hypertension
Rochester, Minnesota

John C. Lieske, MD: researcher: Alnylam, BioMarin, Dicerna, Novobiome, Siemens, Synlogic; consultant/advisor/speaker: Alnylam, BioMarin, Bridgebio, Chinook, Dicerna, FederationBio, Intellia, Novobiome, Synlogic.

George Tidmore (Patient),

George Tidmore has no relevant financial reationships to disclose.